SeABank Completes Basel II Three Pillars Before Deadline
In October 2019, SeABank was approved by the Governor of the SBV before the deadline for the compliance with...
Category: Uncategorized
Bay Area Kids Laptop Company Takes On Systemic Inequalities
OAKLAND, Calif., July 2, 2020 /PRNewswire/ — Silicon Valley startup, Tanoshi, announced today their #ActionMustHappen campaign. The campaign is actively...
Hyundai Mobis Accelerate Mobility Technologies Investing in Overseas VC Funds
SEOUL, South Korea, July 2, 2020 /PRNewswire/ — Hyundai Mobis(KRX:012330), which has been devoted to securing future car technologies by...
inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations
PESSAC, France, July 2, 2020 /PRNewswire/ — inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on...
Erel Margalit, fondateur et Chairman de JVP, est nommé Chairman du conseil d’administration de ThetaRay
NEW YORK et HOD HASHARON, Israël, 2 juillet 2020 /PRNewswire/ — ThetaRay, fournisseur de premier plan en matière d’analyses...
CF PharmTech, Inc. schließt Serie-F-Finanzierung über 50 Mio. US-Dollar ab, um die Kommerzialisierung seiner Inhalationsprodukte zu beschleunigen
SUZHOU, China, 02. Juli 2020 /PRNewswire/ — CF PharmTech, Inc. (www.cfpharmtech.com) gab heute bekannt, dass es nach seiner Serie-E-Finanzierung...
JVP-Gründer und Vorsitzender Erel Margalit wurde zum Vorsitzenden des Vorstands von ThetaRay ernannt
NEW YORK und HOD HASHARON, Israel, 2. Juli 2020 /PRNewswire/ — ThetaRay, der führende Anbieter von Big-Data-Analysen zur Verhinderung...
CF PharmTech, Inc. fecha US$ 50 milhões em financiamentos da série F para acelerar a comercialização de seus produtos de inalação
Doenças respiratórias são prevalentes na China. Há aproximadamente 300 milhões de pessoas sofrendo de asma, doença pulmonar obstrutiva crônica...
CF PharmTech, Inc. cierra una financiación de Serie F por US$50 millones para acelerar la comercialización de sus productos de inhalación
Las enfermedades respiratorias son frecuentes en China. Hay cerca de 300 millones de personas que padecen de asma, enfermedad...
CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.
SUZHOU, China, July 1, 2020 /PRNewswire/ — CF PharmTech, Inc. (“CF PharmTech”) announced today that it has raised US...